Author

R Alvarez

Observed names: R. ALVAREZ, R. Alvarez, Robert Alvarez

OpenAlex ID: A5112138123

Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.

1995 · R Alvarez, C Sette, et al. · Molecular Pharmacology · 129

[3] Determination of adenylyl cyclase catalytic activity using single and double column procedures

1994 · Roger A. Johnson, Robert Alvarez, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 74

The action of SDZ 205,557 at 5‐hydroxytryptamine (5‐HT3 and 5‐HT4) receptors

1993 · R.M. Eglen, R. Alvarez, et al. · British Journal of Pharmacology · 57

A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.

1986 · R Alvarez, G L Banerjee, et al. · Molecular Pharmacology · 43

Activation of cardiac adenylate cyclase: horminal modification of the magnesium ion requirement.

1977 · R Alvarez, J J Bruno · Proceedings of the National Academy of Sciences · 34

On the identification and biological properties of prostaglandin J2

1984 · I. Mahmud, D.L. Smith, et al. · Prostaglandins Leukotrienes and Medicine · 30

Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin

1991 · R. Alvarez, R.M. Eglen, et al. · Prostaglandins · 13

Differences in pulmonary and cardiovascular beta receptors in the guinea pig and rabbit.

1977 · R M Weissberg, J Marian, et al. · Journal of Pharmacology and Experimental Therapeutics · 5

Electrochemical evaluation of the interaction between ascorbic acid and the cardiotonic drug RS-82856.

1987 · G C Visor, L H Lin, et al. · PubMed · 1

ChemInform Abstract: Inhibitors of Cyclic AMP Phosphodiesterase. Part 1. Analogues of Cilostamide and Anagrelide.

1987 · G. H. JONES, M. C. VENUTI, et al. · ChemInform · 1

ChemInform Abstract: Inhibitors of Cyclic AMP Phosphodiesterase. Part 4. Synthesis and Evaluation of Potential Prodrugs of Lixazinone (N‐Cyclohexyl‐N‐methyl‐4‐((1,2,3,5‐tetrahydro‐2‐oxoimidazo(2,1‐b)quinazolin‐7‐yl)oxy)butyramide, RS‐82856).

1989 · M. C. VENUTI, R. ALVAREZ, et al. · ChemInform

ChemInform Abstract: Inhibitors of Cyclic AMP Phosphodiesterase. Part 3. Synthesis and Biological Evaluation of Pyrido and Imidazolyl Analogues of 1,2,3,5‐Tetrahydro‐2‐oxoimidazo(2,1‐b)quinazoline.

1989 · M. C. VENUTI, R. A. STEPHENSON, et al. · ChemInform

ChemInform Abstract: Inhibitors of Cyclic AMP Phosphodiesterase. Part 2. Structural Variations of N‐Cyclohexyl‐N‐methyl‐4‐((1,2,3,5‐tetrahydro‐2‐oxoimidazo‐(2,1‐b)quinazolin‐7‐yl)oxy)butyramide (RS‐82856).

1987 · M. C. VENUTI, G. H. JONES, et al. · ChemInform

QSAR OPTIMIZATION OF ACTIVITY, SELECTIVITY AND LACK OF DEPRESSIVITY FOR A BETA-ADRENERGIC BLOCKER. (±)-1-ISOPROPYL-AMINO-3-(5-[(2-endoBICYCLO[3.1.0]HEX-6-YL)-ETHYLCARBAMOYL]-2-THIAZOLYLOXY)-PROPAN-2-OL MALEATE

1980 · S.H. Unger, K. Untch, et al. · Elsevier eBooks

Works count: 15

Citation count: 387

H-index: 7

I10-index: 7